Education
About Us
Working with TipRanks
Follow Us
Evoke Pharma Inc (DE:EV0)
:EV0
EV0 Stock Chart & Stats
€0.34
€0.00(0.00%)
At close: 4:00 PM EST
€0.34
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.34 - €0.41
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€14.46M
Enterprise Value-€292.02K
Total Cash (Recent Filing)€12.06M
Total Debt (Recent Filing)€5.13M
Price to Earnings (P/E)―
Beta3.53
Next Earnings
Mar 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,558,465
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.20
Price to Sales (P/S)0.82
P/FCF Ratio-1.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Evoke Pharma News
EV0 FAQ
What was Evoke Pharma Inc’s price range in the past 12 months?
Evoke Pharma Inc lowest stock price was €0.34 and its highest was €0.41 in the past 12 months.
What is Evoke Pharma Inc’s market cap?
Evoke Pharma Inc’s market cap is €14.46M.
When is Evoke Pharma Inc’s upcoming earnings report date?
Evoke Pharma Inc’s upcoming earnings report date is Mar 12, 2026 which is in 125 days.
How were Evoke Pharma Inc’s earnings last quarter?
Currently, no data Available
Is Evoke Pharma Inc overvalued?
According to Wall Street analysts Evoke Pharma Inc’s price is currently Overvalued.
Does Evoke Pharma Inc pay dividends?
Evoke Pharma Inc does not currently pay dividends.
What is Evoke Pharma Inc’s EPS estimate?
Evoke Pharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evoke Pharma Inc have?
Evoke Pharma Inc has 1,558,465 shares outstanding.
What happened to Evoke Pharma Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Evoke Pharma Inc?
Currently, no hedge funds are holding shares in DE:EV0
Company Description
Evoke Pharma Inc
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Technical Analysis
China Pharma Holdings
―
Sonoma Pharmaceuticals
―
Shineco
―
Sunshine Biopharma
―
IM Cannabis Corp
―
Options Prices
Currently, No data available
---